Positron Emission Tomography Markets
The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment.
Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Part of that medical imaging improvement is coming from positron emission tomography (PET). PET is a scanning technique used in combination with small amounts of radio-labeled compounds to visualize the anatomy and function of the brain.
The purpose of this report is to describe PET scanning. market. This sector includes all of the generally accepted imaging activities that are currently used in PET, including equipment for PET, PET/CT, SPECT and the use of radiopharmaceuticals for imaging. It examines these clinical measurement devices and their reagents and supplies as used in hospitals and clinics. It also reviews associated clinical market segments in which PET scanning has taken a prominent role including cancer treatment, cardiology, and neurology imaging markets.
Table of Contents
- 1Overview4
- 1.1Statement of Report4
- 1.2Scope of this Report4
- 1.3Methodology5
- 1.4Executive Summary6
- 2Overview of the Medical Imaging Market8
- 2.1Medical Imaging Industry Market Size8
- 2.2Medical Imaging Infrastructure9
- 2.2.1Total Healthcare Expenditures and Demographics9
- 2.2.2Number of Hospitals11
- 2.2.3Number of Radiologists12
- 2.2.4Radiologic Services13
- 2.2.5Medical Imaging Companies15
- 2.2.6Medical Imaging Market Drivers16
- 2.2.7Market Restraints17
- 2.2.8Market Segments for PET Imaging18
- 2.2.9Key Players in the PET Imaging Segment22
- 2.2.10Medical Imaging Sector Analysis24
- 2.3Structure and Use of PET Imaging25
- 2.3.1Functional Imaging versus Anatomic Imaging25
- 2.3.2Functional Imaging Using Single-Photon Imaging (SPECT)26
- 2.3.3PET in Clinical Use29
- 2.3.4PET Sensitivity30
- 2.3.5Therapeutic Uses of PET30
- 2.3.6PET/CT30
- 2.3.7The Future of PET in Cancer Imaging31
- 2.3.8PET Reimbursement31
- 2.4Radiopharmaceutical Imaging32
- 2.4.1Cardinal Health Acquires PET Radiopharmaceutical Production Facilities33
- 2.4.2GE Healthcare Launches New Platform for Automated Synthesis of PET Radiopharmaceuticals33
- 2.4.3Siemens Medical PETNET Radiopharmacy34
- 2.4.4Future Growth of PET Imaging Procedures34
- 2.4.5Diagnostic Radiopharmaceuticals: Market Analysis and Future Prospects34
- 2.4.6New Radiopharmaceutical Applications35
- 3PET Market37
- 3.1Market Size37
- 3.2Total PET and PET/CT Market Trends37
- 3.2.1Market Segmentation and Definitions38
- 3.2.2Overview38
- 3.2.3Market Measurements39
- 3.2.4Market Drivers40
- 3.2.5Market Restraints41
- 3.2.6Future Needs for Market Development42
- 3.2.7Clinical Usages42
- 3.3Total PET and PET/CT Market Forecasts43
- 3.3.1Revenue Forecasts44
- 3.3.2Unit Shipment Forecasts45
- 3.3.3Procedure Forecast46
- 3.3.4Competitive Structure47
- 3.3.5Market Share Analysis49
- 3.3.6Future Directions for PET51
- 3.3.7New PET Technology Platforms52
- 3.4SPECT Market Forecasts53
- 3.5Stand-Alone PET Market Forecasts53
- 3.5.1Revenue Forecasts54
- 3.5.2Unit Shipment Forecasts54
- 3.5.3Market Share Analysis54
- 3.6PET/CT Market Forecasts54
- 3.6.1PET/CT Revenue Forecasts55
- 3.6.2PET/CT Unit Shipment Forecasts55
- 3.6.3PET/CT Market Share Analysis55
- 3.7Products56
- 3.7.1Gamma Medica56
- 3.7.2Mallinckrodt56
- 3.7.3Naviscan PET Systems56
- 3.7.4Siemens Medical56
- 3.7.5TeraRecon56
- 3.7.6Toshiba America Medical Systems56
- 3.7.7CTI Molecular Imaging Inc.56
- 3.7.8GE Healthcare57
- 3.7.9Philips Medical Systems57
- 3.7.10MedImage Inc.57
- 4PET/CT58
- 4.1Strengths of CT and PET Scanning58
- 4.2Combining CT\'s Strengths with PET Scanning58
- 4.3Nuclear Medicine Safety Protocols59
- 4.4PET Safety Protocols60
- 4.4.1Radiation Safety61
- 4.4.2Appropriate Shielding62
- 4.4.3Radioactive Package Protocols63
- 4.5Regulatory Requirements64
- 4.6PET and SPECT Tracers65
- 4.6.1FDG Centers65
- 4.7PET Imaging66
- 4.8PET and Cancer Staging67
- 4.9PET/CT Reimbursement67
- 5Hybrid Technology: PET/CT and SPECT/CT69
- 5.1PET/CT69
- 5.2SPECT/CT69
- 5.2.1Blending of Technology Platforms70
- 5.2.2SPECT vs. PET70
- 6SPECT and SPECT/CT73
- 6.1Single-Photon Emission Computed Tomography (SPECT)73
- 6.1.1SPECT Imaging73
- 6.2SPECT/CT74
- 6.3Potential Applications of SPECT/CT74
- 6.4New Technology Platforms: SPECT77
- 6.1Single-Photon Emission Computed Tomography (SPECT)73
- 7Clinical PET/CT for Oncology Applications78
- 7.1Pulmonary Nodules78
- 7.2Non-Small-Cell Lung Cancer78
- 7.3Melanoma79
- 7.4Lymphoma79
- 7.5Colorectal Cancer80
- 7.6Head and Neck Cancer81
- 7.7Esophageal Cancer81
- 7.8Breast Cancer81
- 7.9Brain Cancer82
- 7.10Prostate Cancer83
- 7.11Ovarian Cancer83
- 7.12Cervical Cancer83
- 7.13Testicular Cancer84
- 7.14Thyroid Cancer84
- 7.15Pancreatic Cancer84
- 7.16Trends in Clinical Use of PET/CT84
- 7.17Development of PET/MRI84
- 8Company Listings86
Other users found this report page using the following search terms: positron pet imaging market pet tomography positron emission imaging petct ct markets growth
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.